Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 Vaccine

NCT07655180 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: COVID-19 mRNA vaccine
DRUG: VYD2311
DRUG: Placebo (Normal Saline)

Sponsor

Invivyd, Inc.